STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Adaptive Biotechnologies Corp

Filed

October 10, 2024

Period of Report

October 8, 2024

Accession Number

0001062993-24-017564